LeMaitre Vascular
LMAT
291 hedge funds and large institutions have $1.95B invested in LeMaitre Vascular in 2024 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 106 increasing their positions, 94 reducing their positions, and 16 closing their positions.
194% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 16
80% more call options, than puts
Call options by funds: $483K | Put options by funds: $269K
15% more capital invested
Capital invested by funds: $1.69B → $1.95B (+$261M)
13% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 94
11% more funds holding
Funds holding: 261 → 291 (+30)
2% more ownership
Funds ownership: 91.45% → 93.45% (+2%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| 1 |
BlackRock
New York
|
+$17.3M |
| 2 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$16.9M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$8.52M |
| 4 |
Goldman Sachs
New York
|
+$4.77M |
| 5 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
+$4.66M |
Top Sellers
LMAT Hedge Fund Activity: Q3 2024 in Review
291 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2024, worth a combined $1.95B — up 15% from $1.69B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new LMAT positions and 16 closed out — a net gain of 31 holders — while 106 added to existing stakes and 94 trimmed.
The largest buyer was BlackRock, adding an estimated $17.3M. The largest seller was Cramer Rosenthal McGlynn, exiting entirely with an estimated $20.5M sold.
- 291 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2024, up from 261 in Q2 2024.
- Funds reported $1.95B of LeMaitre Vascular stock for Q3 2024, up 15% quarter-over-quarter.
- 47 funds opened new LeMaitre Vascular positions in Q3 2024 and 16 closed out, a net change of +31 holders.
- The largest LeMaitre Vascular buyer in Q3 2024 was BlackRock, an estimated $17.3M added.
- The largest LeMaitre Vascular seller in Q3 2024 was Cramer Rosenthal McGlynn, an estimated $20.5M sold.
Based on aggregated 13F filings for Q3 2024.